Product category:
Genomics
News Release from: Panomics | Subject: SNPCapture
Edited by the Laboratorytalk Editorial
Team on 03 December 2003
Seven new SNP screening products
Association for Cell Biology meeting in San Francisco, USA, will see the launch of seven new Elisa mutation detection kits for genotyping
Panomics,a developer of tools for rapid and easy analysis of cell signalling and transcription regulation, says it will be exhibiting seven significant new products for high throughput screening (HTS) at the 2003 Association for Cell Biology 43rd Annual Meeting and Exhibit in San Francisco, California, 12-17 December 2003 Panomics's new SNPCapture Elisa mutation detection kits for genotyping employ a novel, patent pending technology in a hassle-free, high throughput Elisa platform
This article was originally published on Laboratorytalk on 4 Oct 2006 at 8.00am (UK)
Related stories
FDA releases MAQC data in Nature Biotechnology
Panomics has announced the joint publication of the 'Evaluation of DNA Microarray results with quantitative gene expression platforms' in the 8 September 2006 issue of Nature Biotechnology
Haematology analyser fills gap in range
With a throughput of 80 samples per hour, this will suit laboratories with workloads of up to 350 samples per day and fills the gap between 60 and 120 sample per hour machines
Innovative new products emphasise R and D
Completely new bench-top analyser combines the latest technological advances and a large test menu with a faster throughput
Everything you need in the kit is included.
No expensive equipment is required to start or read the assay.
Panomics says that, unlike other available methods, SNPCapture kits are 100% accurate.
The principle behind SNPCapture technology is marvellously simple.
The DNA sample of interest is amplified along with a reference of a known genotype using specially designed, biotinylated primers.
During PCR, a unique DNA structure known as a Holliday junction forms at the SNP site.
If the target and reference duplexes share the same genotype, the Holliday junction resolves into double-stranded DNA; if the genotype differs, the Holliday junction stabilises.
The next step is detecting the stabilised Holliday junctions.
The RuvA protein, which binds to Holliday junctions, is added along with streptavidin-HRP.
The mixture is then incubated in a 96-well microplate well treated with anti-RuvA antibodies.
The presence of Holliday junctions - indicative of a genotype difference - can then be visualised by a simple colour reaction.
There is no need to run gels.
This technology is 100% accurate, provides high throughput, simple, inexpensive and is an all-inclusive kit.
• Panomics: contact details and other news
• Email this article to a colleague
• Register for the free Laboratorytalk email newsletter
• Laboratorytalk Home Page
Search the Pro-Talk network of sites
